Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (141-150 of 428) with videos related to

Pageof 43
Sort By:
The European Respiratory Journal|February 6, 2016
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthmaRichard Beasley, Ian Pavord, Alberto Papi, et al.
The European Respiratory Journal|September 18, 2018
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS studyGary T Ferguson, Alberto Papi, Antonio Anzueto, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trialAlberto Papi, Massimo Corradi, Catherine Pigeon-Francisco, et al.
Allergy|March 10, 2020
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthmaPeter Howarth, Santiago Quirce, Alberto Papi, et al.
Advances in Therapy|January 26, 2020
SABINA: An Overview of Short-Acting β<sub>2</sub>-Agonist Use in Asthma in European CountriesChrister Janson, Andrew Menzies-Gow, Cassandra Nan, et al.
Archivos De Bronconeumologia|February 18, 2026
Association of Comorbidities With Severity and Outcomes of COPD Exacerbations Using the ROMEcom Integrated ScoreMariano Reginato, Lorenzo P Lombardo, Tommaso Bigoni, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|January 17, 2024
From treatable traits to GETomics in airway disease: moving towards clinical practiceAlberto Papi, Rosa Faner, Ian Pavord, et al.
European Journal of Pharmacology|December 28, 2020
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replicationAndrea Marcellini, Dawid Swieboda, Anabel Guedán, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 26, 2021
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE studyCraig LaForce, Bradley E Chipps, Frank C Albers, et al.
Lancet (London, England)|April 8, 2017
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialJørgen Vestbo, Alberto Papi, Massimo Corradi, et al.
Pageof 43

Showing results (141-150 of 428) with videos related to

Sort By:
Pageof 43
The European Respiratory Journal|February 6, 2016
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthmaRichard Beasley, Ian Pavord, Alberto Papi, et al.
The European Respiratory Journal|September 18, 2018
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS studyGary T Ferguson, Alberto Papi, Antonio Anzueto, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trialAlberto Papi, Massimo Corradi, Catherine Pigeon-Francisco, et al.
Allergy|March 10, 2020
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthmaPeter Howarth, Santiago Quirce, Alberto Papi, et al.
Advances in Therapy|January 26, 2020
SABINA: An Overview of Short-Acting β<sub>2</sub>-Agonist Use in Asthma in European CountriesChrister Janson, Andrew Menzies-Gow, Cassandra Nan, et al.
Archivos De Bronconeumologia|February 18, 2026
Association of Comorbidities With Severity and Outcomes of COPD Exacerbations Using the ROMEcom Integrated ScoreMariano Reginato, Lorenzo P Lombardo, Tommaso Bigoni, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|January 17, 2024
From treatable traits to GETomics in airway disease: moving towards clinical practiceAlberto Papi, Rosa Faner, Ian Pavord, et al.
European Journal of Pharmacology|December 28, 2020
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replicationAndrea Marcellini, Dawid Swieboda, Anabel Guedán, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 26, 2021
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE studyCraig LaForce, Bradley E Chipps, Frank C Albers, et al.
Lancet (London, England)|April 8, 2017
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialJørgen Vestbo, Alberto Papi, Massimo Corradi, et al.
Pageof 43